Agency Information Collection Activities: Proposed Collection; Comment Request, 70651-70653 [E8-27523]
Download as PDF
<![CDATA[
Federal Register / Vol. 73, No. 226 / Friday, November 21, 2008 / Notices
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ health care research, quality
improvement and information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: November 12, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. E8–27522 Filed 11–20–08; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Healthcare Research and
Quality
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Agency for Healthcare Research
and Quality, HHS.
ACTION: Notice.
dwashington3 on PRODPC61 with NOTICES
AGENCY:
SUMMARY: This notice announces the
intention of the Agency for Healthcare
Research and Quality (AHRQ) to request
that the Office of Management and
Budget (OMB) approve the proposed
information collection project:
‘‘Improving implementation of the U.S.
Preventive Services Task Force
recommendation for prophylactic
aspirin use among adults at risk for
cardiovascular disease.’’ In accordance
with the Paperwork Reduction Act of
1995, 44 U.S.C. 3506(c)(2)(A), AHRQ
invites the public to comment on this
proposed information collection.
DATES: Comments on this notice must be
received by January 20, 2009.
VerDate Aug<31>2005
14:24 Nov 20, 2008
Written comments should
be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by email at doris.lefkowitz@aahrq.hhs.gov.
Copies of the proposed collection
plans, data collection instruments, and
specific details on the estimated burden
can be obtained from the AHRQ Reports
Clearance Officer.
FOR FURTHER INFORMATION CONTACT:
Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427–1477, or by
e-mail at doris.lefkowitz@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
ADDRESSES:
Jkt 217001
Proposed Project
‘‘Improving implementation of the
U.S. Preventive Services Task Force
recommendation for prophylactic
aspirin use among adults at risk for
cardiovascular disease.’’
This proposed information collection
aims to identify, test and disseminate
methods to improve patient-physician
communication about aspirin
prophylaxis in health care systems. This
project falls under AHRQ’s Accelerating
Change and Transformation in
Organizations and Networks (ACTION)
program and will be conducted for
AHRQ by Abt Associates in
collaboration with Geisinger Health
Systems. ACTION promotes innovation
in health care delivery by accelerating
the development, implementation,
diffusion, and uptake of demand-driven
and evidence-based products, tools,
strategies and findings. ACTION
develops and diffuses scientific
evidence about what does and does not
work to improve health care delivery
systems. The program emphasizes
projects—that are broadly responsive to
user needs and operational interests and
which are expected to be generalizable
across a number of settings.
In this project, a randomized
controlled trial with two intervention
arms and one control arm will be
conducted to evaluate two interventions
designed to improve physician-patient
communication and decision-making
regarding the use of prophylactic aspirin
use among adults at risk for
cardiovascular disease. Each of the three
study arms will take place in one of
three similar clinics.
The first intervention uses a paper
‘‘pre-visit summary’’ handout describing
the benefits and possible harms of daily
low-dose aspirin use to prevent heart
attack in men and stroke in women. The
handout is given to patients in the
waiting room of non-emergency
outpatient clinics. The content of the
handout, including baseline
cardiovascular event risk and the
magnitude of potential benefits and
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
70651
harms of aspirin use, is generated
specifically for each patient using data
in his or her electronic health record.
The purpose of the handout is to
increase the patients’ knowledge of their
own cardiovascular risk and increase
awareness of prophylactic aspirin
regimens as a-treatment option. The
study will assess whether the handout
is effective in stimulating subsequent
discussion with physicians about
cardiovascular risk and aspirin.
The second intervention also uses the
pre-visit summary handout, but adds a
computer-based clinical decision
support tool. During the patient’s visit
with the physician, the electronic health
record software used by the physician
will alert the physician of the patient’s
elevated cardiovascular risk and prompt
the physician to discuss prophylactic
aspirin use with the patient. If the
physician chooses to do so, he or she
can use a computer-based tool as a
decision aid during the discussion with
the patient. The tool displays the
patient’s risk of cardiovascular event
(heart attack or stroke) and the potential
risk-reducing effect of daily aspirin use.
The tool also shows the likelihood of
potential harms of aspirin use (e.g.,
gastrointestinal bleeding). The tool is
interactive and allows the patient and
doctor to explore the expected effects of
behavior change related to modifiable
cardiovascular risk factors (e.g., smoking
cessation) as well as prophylactic
aspirin use.
The proposed data collection supports
the ACTION program mission by
promoting health care quality
improvement. The overall aim of the
study is to explore the effectiveness of
innovative health care delivery methods
in improving patient health behaviors
(i.e., using aspirin prophylaxis). The
study has been constructed to produce
results that will be helpful in a broad
range of clinic settings including those
utilizing electronic health records and
those that rely on paper-based record
systems. The proposed data collection
will assess the study’s main outcome:
initiating a discussion about
prophylactic aspirin use between at-risk
patients and their physicians in order to
facilitate a shared decision-making
process, and is therefore a necessary and
integral element of the overall research
study and of the ACTION program
mission.
This project is being conducted
pursuant to AHRQ’s statutory authority
to conduct and support research on
health care and on systems for the
delivery of such care, including
activities with respect to the quality,
effectiveness, efficiency,
appropriateness and value of health care
E:\FR\FM\21NON1.SGM
21NON1
70652
Federal Register / Vol. 73, No. 226 / Friday, November 21, 2008 / Notices
services 42 U.S.C. 299a(a)(1). The
parties involved in the study will
comply with the Health Insurance
Portability and Accountability Act
(HIPAA) Privacy Rule, 45 CFR parts 160
and 164, and the study will be required
to obtain approval of the institutional
review boards of Geisinger Health
Systems and Abt Associates.
Method of Collection
Data for this study will be collected
directly from study participants
(patients, doctors, and clinic staff) and
indirectly from patients’ electronic
health records and observation of the
intervention in clinic waiting rooms.
The first phase of the direct data
collection will occur after a patient
gives his or her informed consent to
participate in the study and written
authorization for the use of his or her
protected health information for this
study. Patients will complete a 5-minute
pre-visit questionnaire. Fourteen days
after a patient’s visit, he or she will be
contacted to complete a one-time, 25minute telephone follow-up
questionnaire to assess aspirin use,
knowledge, and the relevant patient/
physician encounter. Data will be
collected from participating physicians
through 30-minute semi-structured
interviews. Similarly, a 10-minute semistructured interview of participating
clinic staff will also be administered to
gather information about the feasibility
and perceived effectiveness of the
intervention.
Estimated Annual Respondent Burden
Exhibit 1 presents an estimate of the
annual reporting time burden on
respondents participating in the data
collection process. Time estimates are
based on experience with similar
instruments used with comparable
respondents. A total of 1,000 patients
are expected to participate in the study,
distributed into approximately equal
groups across the three arms of the
study. The pre-visit questionnaire will
be completed by 1,000 respondents and
will take about 5 minutes. The
telephone follow-up questionnaire will
be completed by 1,000 respondents and
will take about 25 minutes. Qualitative
interviews will be conducted with 10
physicians and 8 staff members from
each of the two intervention clinics; the
physician interview will require about
30 minutes while the staff interview
will last about 10 minutes. The total
estimated burden hours for the
respondents’ time to participate in this
data collection is 513 hours.
Exhibit 2 shows the estimated cost
burden based on the respondents’ time
to participate in this project and their
hourly wage. The estimated cost burden
is $10,388.
EXHIBIT 1—ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents
Form name
Number of responses per
respondent
Hours per
response
Total burden
hours
Pre-Visit Questionnaire ....................................................................................
Telephone Follow-up Questionnaire ................................................................
Qualitative Interviews: Physicians ...................................................................
Qualitative Interviews: Clinic Staff ...................................................................
1,000
1,000
2
2
1
1
10
8
5/60
25/60
30/60
10/60
83
417
10
3
Total ..........................................................................................................
2,004
na
na
513
EXHIBIT 2—ESTIMATED ANNUALIZED COST BURDEN
Number of respondents
Form name
Total burden
hours
Average hourly wage rate*
Total cost
burden
Pre-Visit Questionnaire ....................................................................................
Telephone Follow-up Questionnaire ................................................................
Qualitative Interviews: Physicians ...................................................................
Qualitative Interviews: Clinic Staff ...................................................................
1,000
1,000
2
2
83
417
10
3
$19.29
19.29
66.11
27.44
$1,601
8,044
661
82
Total ..........................................................................................................
2,004
513
na
10,388
*National Compensation Survey: Occupational wages in the United States, June 2006, U.S. Department of Labor, Bureau of Labor Statistics.
Estimated Annual Costs to the Federal
Government
The total cost to the government of
this two-year project is expected to be
$300,000. Exhibit 3 details the costs
associated with this project, which
include $74,206 for project
development, $42,760 for data
collection activities, $29,510 for data
processing and analysis, $31,165 for the
publication of results, $27,136 for
project management and $95,222 for
overhead.
EXHIBIT 3—ESTIMATED COST
dwashington3 on PRODPC61 with NOTICES
Cost component
Total cost
Annualized
cost
Project Development .......................................................................................................................................................
Data Collection Activities .................................................................................................................................................
Data Processing and Analysis .........................................................................................................................................
Publication of Results ......................................................................................................................................................
Project Management ........................................................................................................................................................
Overhead .........................................................................................................................................................................
$74,206
42,760
29,510
31,165
27,136
95,222
$37,103
21,380
14,755
15,583
13,568
47,611
Total ..........................................................................................................................................................................
300,000
150,000
VerDate Aug<31>2005
14:24 Nov 20, 2008
Jkt 217001
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
E:\FR\FM\21NON1.SGM
21NON1
Federal Register / Vol. 73, No. 226 / Friday, November 21, 2008 / Notices
Request for Comments
In accordance with the above-cited
Paperwork Reduction Act legislation,
comments on AHRQ’s information
collection are requested with regard to
any of the following: (a) Whether the
proposed collection of information is
necessary for the proper performance of
AHRQ health care research, quality
improvement and information
dissemination functions, including
whether the information will have
practical utility; (b) the accuracy of
AHRQ’s estimate of burden (including
hours and costs) of the proposed
collection(s) of information; (c) ways to
enhance the quality, utility, and clarity
of the information to be collected; and
(d) ways to minimize the burden of the
collection of information upon the
respondents, including the use of
automated collection techniques or
other forms of information technology.
Comments submitted in response to
this notice will be summarized and
included in the Agency’s subsequent
request for OMB approval of the
proposed information collection. All
comments will become a matter of
public record.
Dated: November 6, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. E8–27523 Filed 11–20–08; 8:45 am]
BILLING CODE 4160–90–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[Document Identifier: CMS–416]
Agency Information Collection
Activities: Proposed Collection;
Comment Request
Centers for Medicare &
Medicaid Services.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS) is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the agency’s functions;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
dwashington3 on PRODPC61 with NOTICES
AGENCY:
VerDate Aug<31>2005
14:24 Nov 20, 2008
Jkt 217001
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Annual Early
and Periodic Screening, Diagnostic and
Treatment (EPSDT) Report; Use: States
are required to submit an annual report
on the provision of EPSDT services
pursuant to section 1902(a)(43)(D) of the
Social Security Act. These reports
provide CMS with data necessary to
assess the effectiveness of State EPSDT
programs, to determine a State’s results
in achieving its participation goal and to
respond to inquiries. This collection is
being submitted as a revision based on
minor changes made to the form and
instructions. CMS has added three
additional lines of data to the form
(lines 12d, 12e and 12f). This
information is currently being collected;
however, CMS expanded the lines to
obtain a better understanding for the
utilization of dental services. CMS
believes there will be no additional
burden for the changes made to the
form. The changes were necessary to
accommodate a need for more specific
dental data and to preliminary notify
States of a change in CPT codes. A
clarification was also made to line 14 of
the instructions. Form Number: CMS–
416 (OMB# 0938–0354); Frequency:
Yearly; Affected Public: State, Local or
Tribal Governments; Number of
Respondents: 56; Total Annual
Responses: 56; Total Annual Hours:
1,568.
To obtain copies of the supporting
statement and any related forms for the
proposed paperwork collections
referenced above, access CMS’ Web Site
at https://www.cms.hhs.gov/
PaperworkReductionActof1995, or Email your request, including your
address, phone number, OMB number,
and CMS document identifier, to
Paperwork@cms.hhs.gov, or call the
Reports Clearance Office on (410) 786–
1326.
In commenting on the proposed
information collections please reference
the document identifier or OMB control
number. To be assured consideration,
comments and recommendations must
be submitted in one of the following
ways by January 20, 2009:
1. Electronically. You may submit
your comments electronically to https://
www.regulations.gov. Follow the
instructions for ‘‘Comment or
Submission’’ or ‘‘More Search Options’’
to find the information collection
document(s) accepting comments.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
70653
2. By regular mail. You may mail
written comments to the following
address: CMS, Office of Strategic
Operations and Regulatory Affairs,
Division of Regulations Development,
Attention: Document Identifier/OMB
Control Number, Room C4–26–05, 7500
Security Boulevard, Baltimore,
Maryland 21244–1850.
Dated: November 14, 2008.
Michelle Shortt,
Director, Regulations Development Group,
Office of Strategic Operations and Regulatory
Affairs.
[FR Doc. E8–27711 Filed 11–20–08; 8:45 am]
BILLING CODE 4120–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2008–P–0029]
Determination That NUBAIN
(Nalbuphine Hydrochloride) Injection,
10 and 20 Milligrams/Milliliter, Was Not
Withdrawn From Sale for Reasons of
Safety or Effectiveness
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
SUMMARY: The Food and Drug
Administration (FDA) is announcing its
determination that NUBAIN
(nalbuphine hydrochloride) injection,
10 and 20 milligrams/milliliter (mg/ml),
was not withdrawn from sale for reasons
of safety or effectiveness. This
determination will allow FDA to
approve abbreviated new drug
applications (ANDAs) for nalbuphine
hydrochloride injection, 10 and 20 mg/
ml, if all other legal and regulatory
requirements are met.
FOR FURTHER INFORMATION CONTACT:
Carol E. Drew, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 51, rm. 6306,
Silver Spring, MD 20993–0002, 301–
796–3601.
SUPPLEMENTARY INFORMATION: In 1984,
Congress enacted the Drug Price
Competition and Patent Term
Restoration Act of 1984 (Pub. L. 98–417)
(the 1984 amendments), which
authorized the approval of duplicate
versions of drug products approved
under an ANDA procedure. ANDA
applicants must, with certain
exceptions, show that the drug for
which they are seeking approval
contains the same active ingredient in
the same strength and dosage form as
the ‘‘listed drug,’’ which is a version of
E:\FR\FM\21NON1.SGM
21NON1
]]>Agencies
[Federal Register Volume 73, Number 226 (Friday, November 21, 2008)]
[Notices]
[Pages 70651-70653]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-27523]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Agency for Healthcare Research and Quality
Agency Information Collection Activities: Proposed Collection;
Comment Request
AGENCY: Agency for Healthcare Research and Quality, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the intention of the Agency for
Healthcare Research and Quality (AHRQ) to request that the Office of
Management and Budget (OMB) approve the proposed information collection
project: ``Improving implementation of the U.S. Preventive Services
Task Force recommendation for prophylactic aspirin use among adults at
risk for cardiovascular disease.'' In accordance with the Paperwork
Reduction Act of 1995, 44 U.S.C. 3506(c)(2)(A), AHRQ invites the public
to comment on this proposed information collection.
DATES: Comments on this notice must be received by January 20, 2009.
ADDRESSES: Written comments should be submitted to: Doris Lefkowitz,
Reports Clearance Officer, AHRQ, by e-mail at
doris.lefkowitz@aahrq.hhs.gov.
Copies of the proposed collection plans, data collection
instruments, and specific details on the estimated burden can be
obtained from the AHRQ Reports Clearance Officer.
FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports
Clearance Officer, (301) 427-1477, or by e-mail at
doris.lefkowitz@ahrq.hhs.gov.
SUPPLEMENTARY INFORMATION:
Proposed Project
``Improving implementation of the U.S. Preventive Services Task
Force recommendation for prophylactic aspirin use among adults at risk
for cardiovascular disease.''
This proposed information collection aims to identify, test and
disseminate methods to improve patient-physician communication about
aspirin prophylaxis in health care systems. This project falls under
AHRQ's Accelerating Change and Transformation in Organizations and
Networks (ACTION) program and will be conducted for AHRQ by Abt
Associates in collaboration with Geisinger Health Systems. ACTION
promotes innovation in health care delivery by accelerating the
development, implementation, diffusion, and uptake of demand-driven and
evidence-based products, tools, strategies and findings. ACTION
develops and diffuses scientific evidence about what does and does not
work to improve health care delivery systems. The program emphasizes
projects--that are broadly responsive to user needs and operational
interests and which are expected to be generalizable across a number of
settings.
In this project, a randomized controlled trial with two
intervention arms and one control arm will be conducted to evaluate two
interventions designed to improve physician-patient communication and
decision-making regarding the use of prophylactic aspirin use among
adults at risk for cardiovascular disease. Each of the three study arms
will take place in one of three similar clinics.
The first intervention uses a paper ``pre-visit summary'' handout
describing the benefits and possible harms of daily low-dose aspirin
use to prevent heart attack in men and stroke in women. The handout is
given to patients in the waiting room of non-emergency outpatient
clinics. The content of the handout, including baseline cardiovascular
event risk and the magnitude of potential benefits and harms of aspirin
use, is generated specifically for each patient using data in his or
her electronic health record. The purpose of the handout is to increase
the patients' knowledge of their own cardiovascular risk and increase
awareness of prophylactic aspirin regimens as a-treatment option. The
study will assess whether the handout is effective in stimulating
subsequent discussion with physicians about cardiovascular risk and
aspirin.
The second intervention also uses the pre-visit summary handout,
but adds a computer-based clinical decision support tool. During the
patient's visit with the physician, the electronic health record
software used by the physician will alert the physician of the
patient's elevated cardiovascular risk and prompt the physician to
discuss prophylactic aspirin use with the patient. If the physician
chooses to do so, he or she can use a computer-based tool as a decision
aid during the discussion with the patient. The tool displays the
patient's risk of cardiovascular event (heart attack or stroke) and the
potential risk-reducing effect of daily aspirin use. The tool also
shows the likelihood of potential harms of aspirin use (e.g.,
gastrointestinal bleeding). The tool is interactive and allows the
patient and doctor to explore the expected effects of behavior change
related to modifiable cardiovascular risk factors (e.g., smoking
cessation) as well as prophylactic aspirin use.
The proposed data collection supports the ACTION program mission by
promoting health care quality improvement. The overall aim of the study
is to explore the effectiveness of innovative health care delivery
methods in improving patient health behaviors (i.e., using aspirin
prophylaxis). The study has been constructed to produce results that
will be helpful in a broad range of clinic settings including those
utilizing electronic health records and those that rely on paper-based
record systems. The proposed data collection will assess the study's
main outcome: initiating a discussion about prophylactic aspirin use
between at-risk patients and their physicians in order to facilitate a
shared decision-making process, and is therefore a necessary and
integral element of the overall research study and of the ACTION
program mission.
This project is being conducted pursuant to AHRQ's statutory
authority to conduct and support research on health care and on systems
for the delivery of such care, including activities with respect to the
quality, effectiveness, efficiency, appropriateness and value of health
care
[[Page 70652]]
services 42 U.S.C. 299a(a)(1). The parties involved in the study will
comply with the Health Insurance Portability and Accountability Act
(HIPAA) Privacy Rule, 45 CFR parts 160 and 164, and the study will be
required to obtain approval of the institutional review boards of
Geisinger Health Systems and Abt Associates.
Method of Collection
Data for this study will be collected directly from study
participants (patients, doctors, and clinic staff) and indirectly from
patients' electronic health records and observation of the intervention
in clinic waiting rooms. The first phase of the direct data collection
will occur after a patient gives his or her informed consent to
participate in the study and written authorization for the use of his
or her protected health information for this study. Patients will
complete a 5-minute pre-visit questionnaire. Fourteen days after a
patient's visit, he or she will be contacted to complete a one-time,
25-minute telephone follow-up questionnaire to assess aspirin use,
knowledge, and the relevant patient/physician encounter. Data will be
collected from participating physicians through 30-minute semi-
structured interviews. Similarly, a 10-minute semi-structured interview
of participating clinic staff will also be administered to gather
information about the feasibility and perceived effectiveness of the
intervention.
Estimated Annual Respondent Burden
Exhibit 1 presents an estimate of the annual reporting time burden
on respondents participating in the data collection process. Time
estimates are based on experience with similar instruments used with
comparable respondents. A total of 1,000 patients are expected to
participate in the study, distributed into approximately equal groups
across the three arms of the study. The pre-visit questionnaire will be
completed by 1,000 respondents and will take about 5 minutes. The
telephone follow-up questionnaire will be completed by 1,000
respondents and will take about 25 minutes. Qualitative interviews will
be conducted with 10 physicians and 8 staff members from each of the
two intervention clinics; the physician interview will require about 30
minutes while the staff interview will last about 10 minutes. The total
estimated burden hours for the respondents' time to participate in this
data collection is 513 hours.
Exhibit 2 shows the estimated cost burden based on the respondents'
time to participate in this project and their hourly wage. The
estimated cost burden is $10,388.
Exhibit 1--Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of
Form name Number of responses per Hours per Total burden
respondents respondent response hours
----------------------------------------------------------------------------------------------------------------
Pre-Visit Questionnaire......................... 1,000 1 5/60 83
Telephone Follow-up Questionnaire............... 1,000 1 25/60 417
Qualitative Interviews: Physicians.............. 2 10 30/60 10
Qualitative Interviews: Clinic Staff............ 2 8 10/60 3
---------------------------------------------------------------
Total....................................... 2,004 na na 513
----------------------------------------------------------------------------------------------------------------
Exhibit 2--Estimated Annualized Cost Burden
----------------------------------------------------------------------------------------------------------------
Number of Total burden Average hourly Total cost
Form name respondents hours wage rate* burden
----------------------------------------------------------------------------------------------------------------
Pre-Visit Questionnaire......................... 1,000 83 $19.29 $1,601
Telephone Follow-up Questionnaire............... 1,000 417 19.29 8,044
Qualitative Interviews: Physicians.............. 2 10 66.11 661
Qualitative Interviews: Clinic Staff............ 2 3 27.44 82
---------------------------------------------------------------
Total....................................... 2,004 513 na 10,388
----------------------------------------------------------------------------------------------------------------
*National Compensation Survey: Occupational wages in the United States, June 2006, U.S. Department of Labor,
Bureau of Labor Statistics.
Estimated Annual Costs to the Federal Government
The total cost to the government of this two-year project is
expected to be $300,000. Exhibit 3 details the costs associated with
this project, which include $74,206 for project development, $42,760
for data collection activities, $29,510 for data processing and
analysis, $31,165 for the publication of results, $27,136 for project
management and $95,222 for overhead.
Exhibit 3--Estimated Cost
------------------------------------------------------------------------
Annualized
Cost component Total cost cost
------------------------------------------------------------------------
Project Development........................... $74,206 $37,103
Data Collection Activities.................... 42,760 21,380
Data Processing and Analysis.................. 29,510 14,755
Publication of Results........................ 31,165 15,583
Project Management............................ 27,136 13,568
Overhead...................................... 95,222 47,611
-------------------------
Total..................................... 300,000 150,000
------------------------------------------------------------------------
[[Page 70653]]
Request for Comments
In accordance with the above-cited Paperwork Reduction Act
legislation, comments on AHRQ's information collection are requested
with regard to any of the following: (a) Whether the proposed
collection of information is necessary for the proper performance of
AHRQ health care research, quality improvement and information
dissemination functions, including whether the information will have
practical utility; (b) the accuracy of AHRQ's estimate of burden
(including hours and costs) of the proposed collection(s) of
information; (c) ways to enhance the quality, utility, and clarity of
the information to be collected; and (d) ways to minimize the burden of
the collection of information upon the respondents, including the use
of automated collection techniques or other forms of information
technology.
Comments submitted in response to this notice will be summarized
and included in the Agency's subsequent request for OMB approval of the
proposed information collection. All comments will become a matter of
public record.
Dated: November 6, 2008.
Carolyn M. Clancy,
Director.
[FR Doc. E8-27523 Filed 11-20-08; 8:45 am]
BILLING CODE 4160-90-M
